can semaglutide cause pots A newly published case series reports that GLP-1 receptor agonists (like and tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or Dr. Tania Dempsey on GLP-1s

By targeting two pathways involved in hunger and metabolism, Mounjaro may work more effectively in reducing body weight, especially for those who struggle with severe obesity

Supplementation should always be integrated into a broader protocol that includes aggressive pacing to manage post-exertional malaise, careful symptom tracking, dietary modifications to support histamine clearance, and ongoing medical care from specialists who truly understand the interconnected nature of neuro-immune diseases

The IGF-1 LR3 before and after framing that circulates online often implies a personal transformation timeline, but the actual research picture is more precise its a story of receptor kinetics, signaling cascades, and study-documented outcomes rather than anecdotal results

Push the plunger over 5-10 seconds

doi: 10.1038/bjc.2014.175

Conversely, an episode of shedding may reveal previously compensated follicular miniaturization, leaving persistent patterned loss after the acute process resolves